Related Experiment Video
Updated: Feb 24, 2026

Skeletal Phenotype Analysis of a Conditional Stat3 Deletion Mouse Model
Published on: July 3, 2020
Loss of Hdac3 in osteoprogenitors increases bone expression of osteoprotegerin, improving systemic insulin
Meghan E McGee-Lawrence1,2, Jessica L Pierce1, Kanglun Yu1
1Department of Cellular Biology and Anatomy, Medical College of Georgia, Augusta University, Augusta, Georgia.
Abstract:
Type 2 diabetes is an emerging global health epidemic. Foundations for new therapies are arising from understanding interactions between body systems. Bone-derived factors that reduce RANKL (receptor activator of NF-kappa B ligand) signaling in the liver may prevent insulin resistance and the onset of type 2 diabetes. Here we demonstrate that deletion of the epigenetic regulator, Hdac3, in Osx1-expressing osteoprogenitors prevents insulin resistance induced by high fat diet by increasing serum and skeletal gene expression levels of osteoprotegerin (Opg), a natural inhibitor of RANKL signaling. Removal of one Opg allele in mice lacking Hdac3 in Osx1+ osteoprogenitors increases the insulin resistance of the Hdac3-deficient mice on a high fat diet. Thus, Hdac3-depletion in osteoblasts increases expression of Opg, subsequently preserving insulin sensitivity. The Hdac inhibitor vorinostat also increased Opg transcription and histone acetylation of the Opg locus. These results define a new mechanism by which bone regulates systemic insulin sensitivity.
Insights
Bone epigenetics regulate insulin sensitivity. Deleting Hdac3 in bone cells boosts osteoprotegerin (Opg), preventing type 2 diabetes and insulin resistance. This discovery offers new therapeutic avenues.
Area of Science:
- Endocrinology
- Metabolic Diseases
- Bone Biology
Background:
- Type 2 diabetes is a growing global health concern.
- Understanding inter-system communication is key to developing new therapies.
- Bone-derived factors influencing liver signaling may impact insulin resistance.
Purpose of the Study:
- To investigate the role of the epigenetic regulator Hdac3 in osteoprogenitors.
- To determine if Hdac3 deletion in bone cells affects diet-induced insulin resistance.
- To elucidate the mechanism by which bone influences systemic insulin sensitivity.
Main Methods:
- Utilized genetically modified mice with Hdac3 deletion in Osx1-expressing osteoprogenitors.
- Administered a high-fat diet to induce insulin resistance.
- Measured serum and skeletal gene expression of osteoprotegerin (Opg).
- Assessed insulin sensitivity in Hdac3-deficient mice and controls.
- Investigated the effect of the HDAC inhibitor vorinostat on Opg expression.
Main Results:
- Hdac3 deletion in osteoprogenitors prevented high-fat diet-induced insulin resistance.
- This protective effect was mediated by increased serum and skeletal Opg levels.
- Reducing Opg levels in Hdac3-deficient mice exacerbated insulin resistance.
- The HDAC inhibitor vorinostat increased Opg transcription and histone acetylation at the Opg locus.
Conclusions:
- Hdac3 in osteoprogenitors plays a critical role in regulating systemic insulin sensitivity.
- Bone-derived Opg is a key mediator linking Hdac3 activity in bone to metabolic homeostasis.
- Targeting bone epigenetics, specifically Hdac3 and Opg, presents a novel therapeutic strategy for type 2 diabetes.
More Related Videos
08:34Mechanism of Regulation of Adipocyte Numbers in Adult Organisms Through Differentiation and Apoptosis Homeostasis
Published on: June 3, 2016
10:28Isolation, Expansion, and Adipogenic Induction of CD34+CD31+ Endothelial Cells from Human Omental and Subcutaneous Adipose Tissue
Published on: July 17, 2018
Related Concept Videos
Hormones Regulating Blood Glucose
In addition to accelerating glucose uptake and utilization, insulin has...
Cell Specific Gene Expression
PI3K/mTOR/AKT Signaling Pathway
Osteoclasts in Bone Remodeling
Insulin: The Receptor and Signaling Pathways
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...